REVERSAL OF CD45R ISOFORM SWITCHING IN CD-8+ T-CELLS

被引:45
作者
FUJII, Y
OKUMURA, M
INADA, K
NAKAHARA, K
机构
[1] Immunology Laboratory, First Department of Surgery, Osaka University Medical School, Osaka, 553
关键词
D O I
10.1016/0008-8749(92)90110-B
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Both CD4+ and CD8+ T cells express either CD45RA or CD45RO isoform of CD45R in an exclusive way. Recent reports have shown that CD45RA+ T cells lose CD45RA and gain CD45R0 upon activation. This switching has been suggested to be irreversible although more recently, examples of reversal of CD45R isotype switching in CD4+ T cells have been reported. We report here that freshly isolated unprimed CD8+ T cells, when activated with PHA, temporarily lose CD45RA but reexpress an intermediate level of CD45RA 2-3 weeks after activation with PHA. This reversal seems to take place much more slowly in unprimed CD4+ T cells: the majority of CD4+ T cells that had lost CD45RA and gained CD45RO remained CD45RA-CD45RO+ in 3 weeks after the stimulation. Also, long-term CD8+ CD45RA+ T cell lines stimulated with PHA or OKT3 showed even more rapid recovery of CD45RA while PPD-specific CD4+ T cell clones retained the original CD45RO phenotype 3 weeks after stimulation with PPD or PHA. © 1992.
引用
收藏
页码:176 / 184
页数:9
相关论文
共 19 条
  • [11] EVIDENCE THAT THE LEUKOCYTE-COMMON ANTIGEN IS REQUIRED FOR ANTIGEN-INDUCED LYMPHOCYTE-T PROLIFERATION
    PINGEL, JT
    THOMAS, ML
    [J]. CELL, 1989, 58 (06) : 1055 - 1065
  • [12] CD4+CD45RA+ AND CD4+CD45RA-T-CELL SUBSETS IN MAN MAINTAIN DISTINCT FUNCTION AND CD45RA EXPRESSION PERSISTS ON A SUBPOPULATION OF CD45RA+ CELLS AFTER ACTIVATION WITH CON A
    ROTHSTEIN, DM
    SOHEN, S
    DALEY, JF
    SCHLOSSMAN, SF
    MORIMOTO, C
    [J]. CELLULAR IMMUNOLOGY, 1990, 129 (02) : 449 - 467
  • [13] ROTHSTEIN DM, 1991, J IMMUNOL, V146, P1175
  • [14] SANDERS ME, 1988, J IMMUNOL, V140, P1401
  • [15] SERRA HM, 1988, J IMMUNOL, V140, P1435
  • [16] SMITH SH, 1986, IMMUNOLOGY, V58, P63
  • [17] TERRY LA, 1988, IMMUNOLOGY, V64, P331
  • [18] THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339
  • [19] TONKS N K, 1988, Biochemistry, V27, P8695, DOI 10.1021/bi00424a001